Time to Relapse After 6 and 12 Months' Treatment of Generalized Anxiety Disorder With Venlafaxine Extended Release
Rickels et al.
Arch Gen Psychiatry 2010;67:1274-1281.
ABSTRACT
| FULL TEXT
Brief Intervention for Anxiety in Primary Care Patients
Roy-Byrne et al.
J Am Board Fam Med 2009;22:175-186.
ABSTRACT
| FULL TEXT
Assessment of the dependence potential of the potent high-efficacy 5-HT1A agonist S-14506 in rats
Goudie and Leathley
J Psychopharmacol 1994;8:213-221.
ABSTRACT
Antidepressants for the Treatment of Generalized Anxiety Disorder: A Placebo-Controlled Comparison of Imipramine, Trazodone, and Diazepam
Rickels et al.
Arch Gen Psychiatry 1993;50:884-895.
ABSTRACT
A review of clinical efficacy of 5-HT 1A agonists in anxiety and depression
Deakin
J Psychopharmacol 1993;7:283-289.
Maintenance Drug Treatment of Panic Disorder: I. Results of a Prospective, Placebo-Controlled Comparison of Alprazolam and Imipramine
Schweizer et al.
Arch Gen Psychiatry 1993;50:51-60.
ABSTRACT
Maintenance Drug Treatment for Panic Disorder: II. Short- and Long-term Outcome After Drug Taper
Rickels et al.
Arch Gen Psychiatry 1993;50:61-68.
ABSTRACT
Carbamazepine Treatment in Patients Discontinuing Long-term Benzodiazepine Therapy: Effects on Withdrawal Severity and Outcome
Schweizer et al.
Arch Gen Psychiatry 1991;48:448-452.
ABSTRACT
A Practical Update on Anxiety Disorders and Their Pharmacologic Treatment
Brown et al.
Arch Intern Med 1991;151:873-884.
ABSTRACT
Long-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation
Rickels et al.
Arch Gen Psychiatry 1990;47:899-907.
ABSTRACT
Flumazenil Provocation of Panic Attacks: Evidence for Altered Benzodiazepine Receptor Sensitivity in Panic Disorder
Nutt et al.
Arch Gen Psychiatry 1990;47:917-925.
ABSTRACT
Psychiatry
Glass and Freedman
JAMA 1989;261:2883-2885.
ABSTRACT
